Cartesian Therapeutics Inc
NASDAQ:RNAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cartesian Therapeutics Inc
NASDAQ:RNAC
|
US |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
FR |
|
Absa Group Ltd
OTC:AGRPY
|
ZA |
|
Ence Energia y Celulosa SA
MAD:ENC
|
ES |
|
T
|
Toyota Tsusho Corp
TSE:8015
|
JP |
|
Immutep Ltd
ASX:IMM
|
AU |
|
Polyplex Corp Ltd
NSE:POLYPLEX
|
IN |
|
G
|
General Electric Co
SIX:GE
|
US |
|
Siemens AG
F:SIE
|
DE |
|
N
|
National Australia Bank Ltd
XMUN:NAL
|
AU |
|
A
|
Amata Corporation PCL
SET:AMATA
|
TH |
|
Ferrovial SE
AEX:FER
|
NL |
|
Monrif SpA
MIL:MON
|
IT |
|
TKO Group Holdings Inc
NYSE:TKO
|
US |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
DUS:MOH
|
FR |
|
Franco-Nevada Corp
TSX:FNV
|
CA |
|
F
|
Ford Motor Co
DUS:FMC1
|
US |
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
BIO-Key International Inc
F:BJO
|
US |
|
Fagron NV
OTC:ARSUF
|
BE |
|
A
|
Adevinta ASA
F:AD5B
|
NO |
|
B
|
BHP Group Ltd
NYSE:BHP
|
AU |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
US |
|
P
|
Prosus NV
JSE:PRX
|
NL |
Shareholder Yield
Current shareholder yield for RNAC is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RNAC Price
Cartesian Therapeutics Inc
| Average Annual Return | -32.36% |
| Standard Deviation of Annual Returns | 26.88% |
| Max Drawdown | -96% |
| Market Capitalization | 192.7m USD |
| Shares Outstanding | 26 510 000 |
| Percentage of Shares Shorted | 16.68% |
RNAC Return Decomposition
Main factors of price return
Stock Splits
RNAC's latest stock split occurred on Apr 5, 2024
The company executed a 1-for-30 stock split, meaning that for every 30 shares held, investors received 1 new share.
Before the split, RNAC traded at 0.5041 per share. Afterward, the share price was about 13.31.
The adjusted shares began trading on Apr 5, 2024. This was stock split number 2 in RNAC's history, following the previous one in Dec 1, 2023.
